Stable IL-10: A New Therapeutic That Promotes Tumor Immunity

Cancer Cell - United States
doi 10.1016/j.ccr.2011.11.020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Importance of IL-10 for CTLA-4-Mediated Inhibition of Tumor-Eradicating Immunity

Journal of Immunology
AllergyImmunology
2004English

Toll-Like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling

Cell Reports
BiochemistryGeneticsMolecular Biology
2015English

Nanotherapy That Prevents Trained Immunity and Promotes Tolerance

Indian Journal of Inflammation Research
2019English

Anti-Nkg2a mAb Is a Checkpoint Inhibitor That Promotes Anti-Tumor Immunity by Unleashing Both T and NK Cells

Cell
BiochemistryGeneticsMolecular Biology
2018English

Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2015English

Toward Therapeutic Application of IL-10-producing Regulatory T Cells

Japanese Journal of Clinical Immunology
2013English

Jade-1, a Candidate Renal Tumor Suppressor That Promotes Apoptosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis

Cancer Research
Cancer ResearchOncology
2011English

IL-27-Induced Type 1 Regulatory T-Cells Produce Oxysterols That Constrain IL-10 Production

Frontiers in Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy